Nasdaq27d
The Committee for Medicinal Products for Human Use (CHMP) reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU
STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that the Committee for Medicinal Products for Human Use (CHMP ...
CARBOGEN AMCIS Secures GMP Certification After Successful ANSM Inspection for its Aseptic Drug Product Manufacturing Site
With over 15 years of expertise in developing injectable and liquid pharmaceutical forms, CARBOGEN AMCIS’ Saint-Beauzire site provides tailored solutions for pre-clinical and clinical trials and small ...
Nasdaq27d
The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease
Viehbacher, "Biogen") announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has reaffirmed its positive opinion by consensus for the anti ...
Pharmaceutical Technology16h
How bioconjugation is unlocking the next generation of drug development
Bioconjugation presents an new frontier for pharmaceutical development, providing an option for improved drug efficacy across ...
The Victoria Advocate28d
The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease
You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...
Yahoo Finance28d
Novartis oral Fabhalta® (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)
Basel, February 28, 2025 – Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and ...
Pharmabiz23d
Vertex Pharma receives CHMP positive opinion for label expansion of Kaftrio in combination with ivacaftor
Vertex Pharmaceuticals, a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions, has announced that the ...
Pharmabiz24d
EMA committee recommends approval of AbbVie’s upadacitinib to treat adults with giant cell arteritis
AbbVie announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of upadacitinib (Rinvoq; 15 mg, once ...
Business Insider15d
EQS-News: Quo vadis legalisation: SYNBIOTIC and GOC NEXUS at the International Cannabis Business Conference (ICBC) in Berlin
GOC NEXUS is one of the world's leading providers for the microbiological decontamination of cannabis GACP raw materials into EU GMP medicinal products ... without the use of chemicals and ...